We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

KAI Pharmaceuticals Announces Initiation of Second Phase 2 Study of KAI-4169

News   Jan 09, 2012

 
KAI Pharmaceuticals Announces Initiation of Second Phase 2 Study of KAI-4169
 
 
 

RELATED ARTICLES

Ebola Patients Have a 90% Survival Rate After Injection With New Drugs

News

Two Ebola drugs have proven so effective in a clinical trial that researchers will make the treatments available to anyone infected with the virus in the Democratic Republic of the Congo, where Ebola has killed nearly 1,900 people over the past year.

READ MORE

Taking Back Control Over Antibiotic Resistant Bacteria

News

Scientists have discovered how molecules called rhamnolipids could make common aminoglycoside antibiotics effective against the toughest Staph infections.

READ MORE

Nanoparticle Drugs Pass Through Lymphatics to Destroy Metastases

News

Researchers have developed a strategy to target metastases residing in the lymph nodes, destroying them before they can cause cancer at other locations.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE